Palmoplantar psoriasis affects the palms of hands and soles of feet, but is not to be confused with palmoplantar pustulosis ...

A growing momentum for earlier treatment of psoriasis has the potential to improve outcomes with oral therapies and biologics ...

12% to 15% of people with psoriasis have palmoplantar psoriasis. Palmoplantar pustular psoriasis is a rare form of psoriasis that causes pus-filled blisters to form on the palms or soles of the feet.

A new study published in The Journal of Dermatology revealed that patients with palmoplantar pustulosis (PPP) who were 18 ...

et al "A randomized phase 3b study evaluating the safety and efficacy of risankizumab in adult patients with moderate-to-severe plaque psoriasis with non-pustular palmoplantar involvement" JAAD ...

German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening skin disorder generalised pustular psoriasis (GPP), in ...

and palmoplantar areas, as well as nail psoriasis. But she said that she was excited about icotrokinra. “This novel therapy has the potential to transform the way we treat psoriasis by providing ...

Discover a study that investigates spesolimab, a monoclonal antibody that has been approved as the first GPP-specific therapy ...